Nonmaturation <strong>of</strong> arm arteriovenous fistulas forhemodialysis access: A systematic review <strong>of</strong> riskfactors and results <strong>of</strong> early treatmentEduard H. J. Voormolen, BSc,a,b Abdelkarime Khodadade Jahrome, MD,c Lambertus W. Bartels, PhD,bFrans L. Moll, MD, PhD,c Willem P. Mali, MD, PhD,a and Peter J. Blankestijn, MD, PhD,dUtrecht, The NetherlandsIntroduction: Arteriovenous fistula (AVF) nonmaturation increases reliance <strong>of</strong> hemodialysis patients on grafts andcatheters, exposing them to associated high complication risks. This systematic review assessed the success rates andcomplications <strong>of</strong> therapeutic interventions in arm hemodialysis AVFs experiencing nonmaturation. It also compared theefficacy <strong>of</strong> preoperative clinical factors (eg, age, gender, race), and preoperatively and postoperatively acquiredhemodynamicparameters (eg, arterial diameter or blood flow through the AVF) at stratifying risk <strong>of</strong> nonmaturation.Methods: Two independent researchers used a systematic strategy to search literature databases and extract data fromarticles judged relevant and valid. The evidence base for this review comprised 33 articles, 12 about treatment, and 21concerning risk stratification. A meta-analysis was performed to calculate summary measures for nonmaturationtreatment success and risk stratification efficacy (eg, excess risk and relative risk) <strong>of</strong> preoperative clinical, preoperativehemodynamic, and postoperative hemodynamic risk factors.Results: The success rate <strong>of</strong> early endovascular or surgical treatment, defined as the possibility <strong>of</strong> achieving adequatehemodialysis, averaged 86%, with 1-year primary patencies <strong>of</strong> 51%, 1-year secondary patencies <strong>of</strong> 76%, and complicationrates <strong>of</strong> 9.3%, with 5.5% minor complications. Overall, patients with preoperative clinical risk factors had excessnonmaturation risks <strong>of</strong> 21% (95% confidence interval [CI], 11%-30%) and a relative risk <strong>of</strong> 1.7 (95% CI, 1.3-2.1). Patientswith preoperative hemodynamic risk factors had average estimated excess risks <strong>of</strong> 24% (95% CI, 15%-33%) and a relativerisk <strong>of</strong> 1.7 (95% CI, 1.4-2.0). Patients with hemodynamic risk factors present shortly after operation had excessnonmaturation risks <strong>of</strong> 50% (95% CI, 42%-58%) and a relative risk <strong>of</strong> 4.3 (95% CI, 3.4-5.5).Conclusions: Patients can be treated effectively for AVF nonmaturation early on, and it is possible to identify thosepatients at risk <strong>of</strong> nonmaturation most effectively with an early postoperative assessment <strong>of</strong> hemodynamic risk factors.Additional research is needed that concentrates on adopting the strategy <strong>of</strong> early treatment <strong>of</strong> patients with postoperativerisk factors. ( J Vasc Surg 2009;49:1325-36.)Meta-analysis• 1794 articles 33 articles with 745 patients fit criteria• Summary measures for risk stratification efficacy• Methodological quality <strong>of</strong> studies evaluated• Excess risk and relative risk for non-maturation calculated– Excess risk: The difference between the absolutenonmaturation risk <strong>of</strong> patients considered at risk (ie, patientswith risk factors) and considered not at risk (ie,patientswithout risk factors). A measure <strong>of</strong> 0% means no risk isconferred by the risk factor.– Relative risk: The nonmaturation risk <strong>of</strong> a patient at riskdivided by the nonmaturation risk <strong>of</strong> a patient not at risk. Ameasure <strong>of</strong> 1.0 means no risk is conferred.Voormolen E. J Vasc Surg 2009Meta-analysis•Methodological quality for most studies was poorRisk FactorsExcess Non-maturationRiskRelative Non-maturationRiskPre-operative Clinical Risk Factors 21% (95% CI, 11%-30%) 1.7 (95% CI, 1.3-2.1)Pre-operative Hemodynamic Factors 24% (95% CI, 15%-33%) 1.7 (95% CI, 1.4-2.0)Post-operative Hemodynamic Factors 50% (95% CI, 42%-58%) 4.3 (95% CI, 3.4-5.5)Voormolen E. J Vasc Surg 200987
Hemodialysis Fistula MaturationConsortium (HFMC)• NINDK-sponsored prospective cohort study <strong>of</strong> 600 patients with new AVF• Goal: to better understand predictors and causes <strong>of</strong> AVF maturation• Standardized data collected in 4 domains which comprehensively addressfactors hypothesized to be associated with AVF maturation– Vascular Anatomy (pre- and post AVF creation)• Size, flow parameters, anatomical abnormalities <strong>of</strong> artery and vein as measured by US– Vascular Biology• Functional characteristics assessed by flow mediated dilatation, arterial pulse wavevelocity, and venous capacitance• Morphometric and molecular analyses <strong>of</strong> venous tissue• Plasma biomarker analysis– Clinical Patient Attributes• Demographics, dialysis history, comorbidities• Intra-operative and surgical factors– Processes <strong>of</strong> Care• Pre, intra, and post-operative factors• 485 patients enrolled as <strong>of</strong> 9/17Optimization <strong>of</strong> AVF MaturationPre-operative Maneuvers to OptimizeAVF Maturation• Arm veins need to preserved!– No PICC lines– Blood draws or IV from mid-forearm or hand (notantecubital fossa)• Duplex ultrasound needs to be considered … ifquality <strong>of</strong> vein is questionable on a tourniquetassisted physical exam• Potential central venous stenosis should beanticipated, interrogated if necessary, andavoided88